UBS Group Increases Xometry (NASDAQ:XMTR) Price Target to $22.00

Xometry (NASDAQ:XMTR) had its price objective boosted by stock analysts at UBS Group from $20.00 to $22.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price objective points to a potential downside of 28.10% from the company’s previous close.

Other equities research analysts have also issued reports about the stock. The Goldman Sachs Group boosted their target price on shares of Xometry from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday. Craig Hallum boosted their price objective on shares of Xometry from $20.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday. JMP Securities upped their target price on shares of Xometry from $27.00 to $32.00 and gave the stock a “market outperform” rating in a research report on Friday, October 18th. Cantor Fitzgerald reiterated an “underweight” rating and set a $12.00 price target on shares of Xometry in a research report on Wednesday. Finally, Royal Bank of Canada upped their price target on Xometry from $23.00 to $27.00 and gave the stock a “sector perform” rating in a report on Wednesday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Xometry presently has an average rating of “Hold” and a consensus target price of $26.29.

Xometry Price Performance

Shares of NASDAQ:XMTR opened at $30.60 on Wednesday. The company has a quick ratio of 4.60, a current ratio of 4.64 and a debt-to-equity ratio of 0.89. The company has a 50-day moving average price of $19.35 and a 200 day moving average price of $16.65. Xometry has a 52 week low of $11.08 and a 52 week high of $38.74. The company has a market cap of $1.51 billion, a P/E ratio of -28.39 and a beta of 0.55.

Xometry (NASDAQ:XMTR) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.13. Xometry had a negative return on equity of 10.75% and a negative net margin of 10.53%. The firm had revenue of $132.60 million for the quarter, compared to the consensus estimate of $128.65 million. During the same period in the previous year, the business earned ($0.55) earnings per share. The company’s revenue for the quarter was up 19.5% compared to the same quarter last year. Research analysts predict that Xometry will post -0.81 earnings per share for the current year.

Insider Buying and Selling at Xometry

In other news, CTO Matthew Leibel sold 3,400 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $18.45, for a total transaction of $62,730.00. Following the completion of the transaction, the chief technology officer now directly owns 82,918 shares of the company’s stock, valued at $1,529,837.10. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 16.79% of the company’s stock.

Institutional Trading of Xometry

A number of large investors have recently made changes to their positions in the stock. State Board of Administration of Florida Retirement System grew its stake in Xometry by 22.1% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 11,840 shares of the company’s stock worth $200,000 after acquiring an additional 2,140 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Xometry by 2.0% during the first quarter. Vanguard Group Inc. now owns 3,877,346 shares of the company’s stock worth $65,488,000 after purchasing an additional 76,976 shares during the last quarter. Texas Capital Bank Wealth Management Services Inc purchased a new stake in shares of Xometry in the first quarter valued at $169,000. Clearbridge Investments LLC increased its stake in Xometry by 20.7% in the first quarter. Clearbridge Investments LLC now owns 1,270,631 shares of the company’s stock valued at $21,461,000 after purchasing an additional 217,939 shares during the last quarter. Finally, Sylebra Capital LLC lifted its position in Xometry by 1,005.3% during the first quarter. Sylebra Capital LLC now owns 644,262 shares of the company’s stock worth $10,882,000 after buying an additional 585,971 shares during the period. Institutional investors and hedge funds own 97.31% of the company’s stock.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.